News
Broad access to the fruits of NIH’s investments—whether in the form of data, results, or products—drives innovation. To advance this aim, NIH is launching a new policy to improve access to medical products developed from NIH-owned inventions. This policy emphasizes the importance of proactive
Scientists from the National Institute of Aging (NIA) at National Institutes of Health (NIH) in collaboration with Tawain's National Health Research Institutes and Case Western Reserve University School of Medicine worked with Peptron Inc. a Korean-based public pharmaceutical company to develop a
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health recently report that genetically modified broadly neutralizing antibodies (bNAbs) protected rhesus macaques from an HIV-like virus. Single infusions of each modified bNAb
Dr. Jorge Munoz will discuss the CDC Trioplex real-time RT-PCR assay for detection and differentiation of Zika, dengue and chikungunya virus infections in one clinical sample. To participate, please pre-register by sending an email to tto@cdc.gov by Thursday, April 26, at 1 p.m. EDT. After